US Patent 10927173 Humanized, mouse or chimeric anti-CD47 monoclonal antibodies
Patent 10927173 was granted and assigned to Forty Seven on February, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 11, 2017
Date of Patent
February 23, 2021
Patent Applicant
Patent Application Number
16068874
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10927173 Humanized, mouse or chimeric anti-CD47 monoclonal antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
